Cortendo
Radnor, US · Founded 2015 · Incorporated in Ireland · 1 known investors
Founders & leadership
RT
Ruth Thieroff-EkerdtExecutive
RL
Robert LutzExecutive
AL
Alexander LindstromExecutive
MP
Matthew PaulsExecutive
Board
ES
Eigil Stray SpetalenBoard director
ET
Espen Tidemann JorgensenBoard director
MS
Marten SteenBoard director
EE
Ernest Eichenberg IIIBoard director
HH
Hilde H. SteinegerBoard director
HJ
H. Joseph ReiserBoard director
JM
Joseph M. MahadyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$220.6M disclosed across 4 rounds · 2015–2016
▶$35MraisedDec 2016 · 23 investors · PharmaceuticalsRule 506(b)
▶$35MraisedDec 2016 · 23 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Garheng KongDirector
- Stephen LongExecutive Officer
- Jeffrey W. ShermanDirector
- Marten SteenDirector
- John JohnsonDirector
- A. Brian DavisExecutive Officer
- Fredric CohenExecutive Officer
- Richard KollenderDirector
- Robert LutzExecutive Officer
- Hilde H. SteinegerDirector
- Matthew PaulsExecutive Officer, Director
- Offering amount
- $35M
- Amount sold
- $35M
- Sales commissions
- $2.1M
- Placement agents
- Stifel, Nicolaus & Company, Incorporated, Arctic Securities LLC
- First sale
- Dec 2016
- Incorporated
- Other, Ireland, 2015
- Federal exemptions
- 06b
▶$126MraisedSep 2015 · 46 investors · PharmaceuticalsRule 506(c)
▶$126MraisedSep 2015 · 46 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Marten SteenDirector
- Ruth Thieroff-EkerdtExecutive Officer
- A. Brian DavisExecutive Officer
- Hilde H. SteinegerDirector
- Robert LutzExecutive Officer
- Stephen LongExecutive Officer
- Garheng KongDirector
- John JohnsonDirector
- Richard KollenderDirector
- Matthew PaulsExecutive Officer, Director
- Offering amount
- $126M
- Amount sold
- $126M
- First sale
- Aug 2015
- Incorporated
- Other, Ireland, 2015
- Federal exemptions
- 06c
▶$33.2MraisedJul 2015 · 25 investors · PharmaceuticalsRule 506(b)
▶$33.2MraisedJul 2015 · 25 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Brian DavisExecutive Officer
- Hilde H. SteinegerDirector
- Eigil Stray SpetalenDirector
- Marten SteenDirector
- Steve LongExecutive Officer
- Richard KollenderDirector
- Matthew PaulsExecutive Officer
- Joseph M. MahadyDirector
- Ruth Thieroff-EkerdtExecutive Officer
- Robert LutzExecutive Officer
- John JohnsonDirector
- Offering amount
- $33.2M
- Amount sold
- $33.2M
- Sales commissions
- $370K
- Placement agents
- Locust Walk Securities, LLC
- First sale
- Jun 2015
- Incorporated
- Other, Sweden
- Federal exemptions
- 06b
▶$26.4MraisedFeb 2015 · 5 investors · PharmaceuticalsRule 506(b)
▶$26.4MraisedFeb 2015 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ruth Thieroff-EkerdtExecutive Officer
- Ernest Eichenberg IIIDirector
- Eigil Stray SpetalenDirector
- Hilde H. SteinegerDirector
- H. Joseph ReiserDirector
- Robert LutzExecutive Officer
- Alexander LindstromExecutive Officer
- Joseph M. MahadyDirector
- Espen Tidemann JorgensenDirector
- Marten SteenDirector
- Matthew PaulsExecutive Officer
- Offering amount
- $26.4M
- Amount sold
- $26.4M
- First sale
- Feb 2015
- Incorporated
- Other, Sweden
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Cortendo's investors?
- Cortendo's investors include HealthCap.
- How much funding has Cortendo raised?
- Cortendo has disclosed $220.6M raised across 4 rounds.
- Where is Cortendo headquartered?
- Cortendo is headquartered in Radnor, US.